Filing
4th Quarter - Amendment
Bills named in this filing
1
Lobbying activity
3
Access Issues, Cancer Drug Parity Act, Safe Step Act
CDMRP's PRCRP
H.R. 9747, (P.L. 118-83) the FY2025 Continuing Appropriations and Extensions Act: Cancer Research, Appropriations: Cancer Research, NIH, CDC, NCI, DoD, ARPA-H